Watanabe’ group demonstrated that the inhibition of SLC7A11 including SAS treatment may overcome resistance to vorinostat by accumulating ROS and inducing ferroptosis in human breast cancer cell and colon cancer cell (Miyamoto et al., 2020). This evidence concerns the gene SLC7A11 and breast cancer.